Sponsor Pipeline

HuniLife Biotechnology, Inc. Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
1
Active Trials
0
Recruiting
1
Disease Areas
Active Trials by Phase
Phase 1/2
1
Active Trials
NCT IDTitleConditionStatus
Phase 1/2
NCT07210047 Study of HuL001 in Relapsed/Refractory Multiple Myeloma Patients Multiple Myeloma Refractory Enrolling by Invitation
Disease Areas
Multiple Myeloma (1)
Get alerts when HuniLife Biotechnology, Inc.'s trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free